Uterine artery embolization for heavy menstrual bleeding

Review OA: closed
📄 Open PDF View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-04 ⓘ

This paper reviews the evolution of uterine artery embolization from a controversial procedure to an established treatment for fibroid-associated heavy menstrual bleeding, noting ongoing research into its merits relative to other options for women wishing to maintain fertility.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Uterine artery embolization (UAE) as a treatment option for fibroids was first reported by Ravina in 1995. Although rapidly adopted by enthusiasts, many were skeptical and its introduction varied widely across the globe. It was not until randomized controlled trials and registries were published and national guidance statements issued that UAE was accepted as a safe and proven treatment for fibroids. The technique is now established as one of the treatment options to be discussed with patients as an alternative to surgery for fibroid-associated heavy menstrual bleeding. Research is on-going to evaluate the relative merits of UAE compared with other medical and surgical treatment options for heavy menstrual bleeding, particularly for women wishing to maintain their fertility.

My notes (saved in your browser only)

MeSH descriptors

Metrorrhagia Uterine Artery Embolization Female Humans Leiomyoma Leiomyoma Leiomyoma Metrorrhagia Uterine Artery Embolization Uterine Neoplasms Uterine Neoplasms Uterine Neoplasms Women's Health

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-18T09:30:06.152893+00:00
pubmed
last seen: 2026-10-08T21:17:08.544769+00:00